| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 May 24 | EXEL Exelixis | Common Stock | Grant | Acquire A | No | No | 0 | 18,838 | 0.00 | 1,279,416 |
| 20 May 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.01 | 60,000 | 120.60 k | 60,000 |
| 20 May 24 | EXEL Exelixis | Common Stock | Sell | Dispose S | No | No | 21 | 11,437 | 240.18 k | 1,260,578 |
| 20 May 24 | EXEL Exelixis | Common Stock | Option exercise | Acquire M | No | No | 19.57 | 11,686 | 228.70 k | 1,272,015 |
| 20 May 24 | EXEL Exelixis | Option Common Stock | Option exercise | Dispose M | No | No | 19.57 | 11,686 | 228.70 k | 0 |
| 16 May 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.01 | 30,000 | 60.30 k | 30,000 |
| 14 Mar 24 | RGLS Regulus Therapeutics | Common Stock | Grant | Acquire A | No | No | 1.6 | 250,000 | 400.00 k | 978,388 |
